Proniosomal powder of captopril: Formulation and evaluation

Molecular Pharmaceutics

Volumn 4, Issue 4, 2007, Pages 596-599

  Gupta, Ankur ^a   Prajapati, Sunil Kr ^a   Singh, Mamta ^a   Balamurugan, M ^a  

^a ISI 15   (India)

Author keywords

Captopril; Niosomes; Proniosomes; Sorbitol

Indexed keywords

CAPTOPRIL;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRY POWDER; ENCAPSULATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

CAPTOPRIL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS; SURFACE-ACTIVE AGENTS; TEMPERATURE; TIME FACTORS;

EID: 34548149561     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0700110     Document Type: Article

References (16)

1. Kumhar, S. K.; Jain, S. K.; Pancholi, S. S.; Agrawal, S.; Saraf, D. K.; Agrawal, G. P. Provesicular Transdermal Drug Delivery System of Ethinylestradiol and Levonorgestrel for Contraception and Hormone Replacement Therapy. Indian J. Pharm. Sci. 2003, 65 (6), 620-627.
2. Blazek-Welsh, A. I.; Rhodes, D. G. Maltodextrin-based Proniosomes. AAPS Pharm. Sci. 2001, 3 (1), 1-8.
3. Hu, C.; Rhodes, D. G. Proniosomes: a Novel Drug Carrier Preparation. Int. J. Pharm. 1999, 185 (1), 23-35.
4. Levy, M.; Koren, G.; Klien, J.; Mclorie, G.; Balfe, J. W. Capopril pharmacokinetics, blood pressure response and plasma rennin activity in normotensive children with renal scarring. Dev. Pharmacol. Ther. 1991, 4, 185-193.
5. Testa, M. A.; Anderson, R. B.; Nackley, J. F.; Hollenberg, N. K. Quality of life and hypertensive therapy in men: a comparison of captopril and enalapril. New Engl. J. Med. 328, 907-913.
6. Brogen, R. N.; Todd, P. A.; Sorkin, E. M. Captopril: an update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1988, 36, 540, 600.
7. Wilding, I. R.; Davis, S. S.; Bkhshaee, M.; Stevens, H. N.; Sparrow, R. A. Gastrointestinal transit and systemic absorption of captopril from a pulsed released formulation. Pharm. Res. 1992, 9 (5), 654-657.
8. Abubkar, O. Nur; Jun, S. Z. Recent progress in sustained/ controlled oral delivery of capopril: an overview. Int. J. Pharm. 2000, 194, 139-146.
9. Nagarsenker, M. S.; Londhe, V. Y.; Nagkarn, G. D. Preparation and evaluation of liposomal formulation of tropicamide for ocular delivery. Int. J. Pharm. 1999, 190, 63-71.
10. Bhatia, A.; Kumar, R.; Katare, O. P. Tamoxifen in topical liposomes: Development, characterization and in-vitro evaluation. J. Pharm. Pharm. Sci. 2004, 7 (2), 252-259.
11. Varghese, V.; Vitta, P.; Bakshi, V.; Agarwal, S.; Pandey, S. Niosomes of Primaquine: Effect of Sorbitan Esters (Spans) on the Vesicular Physical Characterstics. Indian Drugs 2004, 41 (2), 101-103.
12. De Gier, J.; Mandersloot, J. G.; Van Deenan, L. L. M. Lipid Composition and Permeability of Liposomes. Biochem. Biophys. Acta 1968, 150, 666-675.
13. Wan, L. S. C.; Lee, P. F. S. Studies on Surface Film of Sorbitan Esters at the Air/Water Interface. Can. J. Pharm. Sci. a 1974, 9, 82-85.
14. Jia You, F.; Song, Y. Y.; Pao, C. W.; Yaw, B. H.; Yi-Hung, T. In-Vitro Skin Permeation of Estradiol from various Proniosomes Formulations. Int. J. Pharm. 2001, 215, 91-99.
15. Jain, N. K.; Vora, B.; Khopade, A. J. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Controlled Release 1998, 54, 149-165.
16. Varshosaz, J.; Pardakhty, A.; Baharanchi, S. M. Sorbitanmonopalmitate- based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Delivery 2005, 12 (2), 75-82.